Live from the NIH registry
Studies recruiting near Lancaster right now
Top 25 of 103 recruiting studies, sorted by proximity — each links to its official registry page
To Evaluate the Safety and Efficacy of MANP in Subjects With Difficult to Control/ Resistant Hypertension
Difficult to Control Hypertension
Phase 2
Interventional 120 participants sought
Amicis Research Center - Palmdale — Palmdale, California (8.6 mi)
· Sponsor: E-Star BioTech, LLC
A Study of LBP-EC01 in the Treatment of Acute Uncomplicated UTI Caused by Drug Resistant E. Coli (ELIMINATE Trial)
Urinary Tract Infections
Phase 2
Interventional 318 participants sought
Research Site 131 — Lancaster, California (2.2 mi)
· Sponsor: Locus Biosciences
A Study of Eltrekibart and Mirikizumab in Adult Patients With Moderately to Severely Active Ulcerative Colitis
Ulcerative Colitis, Ulcerative Colitis Chronic
Phase 2
Interventional 143 participants sought
Om Research, LLC — Lancaster, California (2.2 mi)
· Sponsor: Eli Lilly and Company
Non-healing Venous Leg Ulcers Treated With Standard Care With or Without BR-AC
Non-infected Venous Leg Ulcer, Venous Leg Ulcer
N/A
Interventional 60 participants sought
Site 19 — Palmdale, California (8.6 mi)
· Sponsor: BioStem Technologies
Paclitaxel Coated Balloon for the Treatment of Chronic bEnigN sTricture- Bowel
Bowel; Stricture
Phase 3
Interventional 171 participants sought
Gastro Care Institute — Lancaster, California (2.2 mi)
· Sponsor: GIE Medical
A Clinical Trial to Evaluate Efficacy and Safety of Xeomin® Injections for Preventing Episodic Migraine
Episodic Migraine
Phase 3
Interventional 990 participants sought
Chemidox Clinical Trials Inc, Merz Investigational Site #0010488 — Lancaster, California (2.2 mi)
· Sponsor: Merz Therapeutics GmbH
Testing the Safety and Tolerability of the Anti-cancer Drugs Trastuzumab Deruxtecan and Neratinib for Cancers With Changes in the HER2 Gene
Metastatic Malignant Solid Neoplasm, Metastatic Pancreatic Adenocarcinoma
Phase 1
Interventional 58 participants sought
City of Hope Antelope Valley — Lancaster, California (2.2 mi)
· Sponsor: National Cancer Institute (NCI)
A Study to Investigate Efficacy and Safety of SAR442970 in Patients With Crohn's Disease
Crohn's Disease
Phase 2
Interventional 99 participants sought
Investigational Site Number: 8400001 — Lancaster, California (2.2 mi)
· Sponsor: Sanofi
Seladelpar in Subjects With Primary Biliary Cholangitis (PBC) and Compensated Cirrhosis
Primary Biliary Cholangitis
Phase 3
Interventional 318 participants sought
OM Research LLC — Lancaster, California (2.2 mi)
· Sponsor: Gilead Sciences
Testing the Addition of an Anti-Cancer Drug, TRC102, to the Usual Chemotherapy Treatment (Pemetrexed, Cisplatin or Carboplatin) During Radiation Therapy for Stage III Non-Squamous Non-Small Cell Lung Cancer
Lung Adenocarcinoma, Lung Large Cell Carcinoma
Phase 2
Interventional 42 participants sought
City of Hope Antelope Valley — Lancaster, California (2.2 mi)
· Sponsor: National Cancer Institute (NCI)
A Study of Amivantamab in Combination With Lazertinib, or Amivantamab in Combination With Platinum-Based Chemotherapy, for Common Epidermal Growth Factor Receptor (EGFR)-Mutated Locally Advanced or Metastatic Non-Small Cell Lung Cancer (NSCLC)
Carcinoma, Non-Small-Cell Lung
Phase 2
Interventional 480 participants sought
City of Hope Antelope Valley — Lancaster, California (2.2 mi)
· Sponsor: Janssen Research & Development, LLC
A Study to Evaluate the Efficacy and Safety of IMG-007 in Adult Participants With Moderate-to-Severe Atopic Dermatitis
Atopic Dermatitis, Atopic Dermatitis Eczema
Phase 2
Interventional 405 participants sought
Inmagene Site 1 — Lancaster, California (2.2 mi)
· Sponsor: Inmagene LLC
A Study of LY4005130 in Adult Participants With Severe Alopecia Areata (Hair Loss)
Alopecia Areata
Phase 2
Interventional 60 participants sought
Cura Clinical Research - Santa Clarita - Kelly Johnson Parkway — Santa Clarita, California (29.5 mi)
· Sponsor: Eli Lilly and Company
This Study Evaluates the ALPCO Syphilis-T and Syphilis-NT CLIA Kits for Detecting Syphilis Antibodies in Serum and Plasma. Samples From At-risk, HIV-positive, Pregnant, and Healthy Individuals Will Assess Assay Performance Versus Established Comparator Tests.
Treponema Pallidum, Treponema Pallidum Infection
N/A
Observational 1,000 participants sought
Chemidox Clinical Trials California — Lancaster, California (2.2 mi)
· Sponsor: American Laboratory Products Company
A Protocol of Icotrokinra Therapy in Adult and Adolescent Participants With Moderately to Severely Active Ulcerative Colitis
Colitis, Ulcerative
Phase 3
Interventional 882 participants sought
Om Research LLC — Lancaster, California (2.2 mi)
· Sponsor: Janssen Research & Development, LLC
Colon Adjuvant Chemotherapy Based on Evaluation of Residual Disease
Stage III Colon Cancer
Phase 2, Phase 3
Interventional 1,912 participants sought
City of Hope Antelope Valley — Lancaster, California (2.2 mi)
· Sponsor: NRG Oncology
A Study to Assess Disease Activity and Adverse Events of Intravenous (IV) Telisotuzumab Vedotin Compared to IV Docetaxel in Adult Participants With Previously Treated Non-Squamous Non-Small Cell Lung Cancer (NSCLC)
Non Small Cell Lung Cancer
Phase 3
Interventional 768 participants sought
City Of Hope - Antelope Valley /ID# 263138 — Lancaster, California (2.2 mi)
· Sponsor: AbbVie
Stereotactic Radiosurgery Compared With Hippocampal-Avoidant Whole Brain Radiotherapy (HA-WBRT) Plus Memantine for 5 or More Brain Metastases
Brain Metastases
Phase 3
Interventional 206 participants sought
City of Hope Antelope Valley — Lancaster, California (2.2 mi)
· Sponsor: Canadian Cancer Trials Group
Paclitaxel Coated Balloon for the Treatment of Chronic bEnigN sTricture- Esophagus
Esophageal Stricture
Phase 3
Interventional 198 participants sought
Gastro Care Institute — Lancaster, California (2.2 mi)
· Sponsor: GIE Medical
Testing Early Treatment for Patients With High-Risk Chronic Lymphocytic Leukemia (CLL) or Small Lymphocytic Leukemia (SLL), EVOLVE CLL/SLL Study
Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma
Phase 3
Interventional 247 participants sought
City of Hope Antelope Valley — Lancaster, California (2.2 mi)
· Sponsor: National Cancer Institute (NCI)
Docetaxel to Androgen Receptor Pathway Inhibitors in Patients With Metastatic Castration Sensitive Prostate Cancer and Suboptimal PSA Response
Prostate Cancer (Adenocarcinoma)
Phase 3
Interventional 830 participants sought
City of Hope Antelope Valley — Lancaster, California (2.2 mi)
· Sponsor: Canadian Cancer Trials Group
A Research Study Comparing How Well Different Doses of the Medicine NNC0662-0419 Lower Blood Sugar in People With Type 2 Diabetes
Diabetes Mellitus, Type 2
Phase 2
Interventional 270 participants sought
First Valley Medical Group — Lancaster, California (2.2 mi)
· Sponsor: Novo Nordisk A/S
A Study to Assess the Safety and Efficacy of Oral Armour Thyroid Compared to Synthetic T4 for the Treatment of Primary Hypothyroidism in Adult Participants
Hypothyroidism
Phase 2, Phase 3
Interventional 2,800 participants sought
Care Access - Santa Clarita /ID# 262573 — Santa Clarita, California (29.5 mi)
· Sponsor: AbbVie
E-Mindfulness Approaches for Living After Breast Cancer
Breast Cancer, Depression
Phase 3
Interventional 402 participants sought
USC Norris Santa Clarita Oncology — Santa Clarita, California (29.5 mi)
· Sponsor: NRG Oncology
Ultra-hypofractionated Whole Breast Irradiation With Lumpectomy Cavity Boost for the Treatment of Stage I-III Breast Cancer
Anatomic Stage I Breast Cancer AJCC v8, Anatomic Stage II Breast Cancer AJCC v8
Phase 2
Interventional 82 participants sought
City of Hope Antelope Valley — Lancaster, California (2.2 mi)
· Sponsor: City of Hope Medical Center